Comparative study on complete remission rate and overall survival in three groups classified based on the serum interleukin-18 level in non-Hodgkin's lymphoma patients.
Takubo
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, 1-4-3, Asahimachi, Abeno-ku, Osaka 545-8585, Japan. m3542254@med.osaka-cu.ac.jp
Kumura
T
T
Nakao
T
T
Nakamae
H
H
Aoyama
Y
Y
Nishiki
S
S
Kinoshita
Y
Y
Koh
K R
KR
Ohta
K
K
Yamane
T
T
Hino
M
M
Kamitani
T
T
Tatsumi
N
N
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D015331:Cohort Studies; D005260:Female; D006801:Humans; D020382:Interleukin-18 / Q000097:blood*; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012074:Remission Induction; D015996:Survival Rate
D020382:Interleukin-18